Patient focused research
What is patient focused research?
We know that recovering from a stem cell transplant can be a long and difficult journey for many of our patients. Some of these challenges are a result of the transplant itself, but others arise because improvements need to be made within the healthcare system.
Our patient-reported outcomes research aims to give us a better understanding of these challenges and the impact they have on our patients. Based upon our research we develop solutions to meet patient need and campaign for policy change. We also share our research findings with the wider stem cell transplant community to ensure patient-centred evidence is at the heart of clinical and supportive care.
How we work
The Anthony Nolan team are experienced in conducting research using qualitative and quantitative methods such as:
• Literature reviews
• Surveys
• Patient-reported outcome assessments
• Interviews
• Focus groups
• Co-design and piloting of interventions
Patient and public involvement is central to the patient-reported outcomes research conducted at Anthony Nolan. Patient advisory groups shape the research questions we ask and provide input on the methods we use. Each patient advisory group is made up of up to six individuals with either lived experience of receiving a stem cell transplant or experience of caring for someone who has received a stem cell transplant. We consider all aspects of stem cell transplantation from the management of early side-effects to establishing late effects clinics, vaccinations and palliative care.
We also work closely with clinicians and allied health professionals to better understand their perceptions of the healthcare they provide, the challenges they face and how we can make, or advocate for, improvements to transplant services.
Group leader profile
Dawn Hart
Dawn Hart
Director of Patient Services
Dawn Hart is the Director of Patient Services at Anthony Nolan and leads the Patient Services Team who are responsible for the production and development of all our patient information and patient (and family) support services.
As a registered nurse with a wealth of experience, Dawn has spent several years working in haematology and chemotherapy caring for, and supporting, patients and their families as they navigated their treatment journeys. Throughout her professional nursing career, she has held a variety of roles within the NHS in both hospital and community settings, including as a Clinical Nurse Specialist, Matron, and Directorate Manager. She has also undertaken Public Health research on suicide prevention, and most recently been part of the Clinical Leadership Team at Hospice UK.
Dawn and the team are now delivering a new area of Anthony Nolan research that focuses on the patient in a way that is meaningful to them throughout their transplant journey.
Team members
- Dawn Hart – Director of Patient Services
- Rachel Miller – Lead Nurse
- Sue Newell – Head of Patient Involvement
- Karen Dean – Clinical Support Co-ordinator
Get involved in our work
If you are a healthcare professional in the field of hematology and transplant care, and you’re interested in helping with our research, please do get in touch to discuss how we can work together.
Examples of current projects
PrEQoL – A Pilot study to Evaluate the collection of socioeconomic and Quality of Life data from patients undergoing allogeneic haematopoietic cell transplantation (HCT)
The purpose of PrEQoL is to pilot the collection of demographic (namely ethnicity and socioeconomic status) and quality of life data among allogeneic HCT recipients using a digital web-based tool hosted by Anthony Nolan. Allogeneic HCT patients will be invited to complete a brief demographic and quality of life questionnaire at four timepoints: before transplant conditioning, on the day of their transplant, 28 days post-transplant and 100 days post-transplant. The primary outcome of PrEQoL is percentage uptake (recruitment rate) at baseline and percentage drop-out (participant retention) at each data collection interval (Day 0, Day 28, and Day 100). Secondary outcomes include completion rates of outcome measures, patterns of missing data, and participant experience and satisfaction with participation within the study (collected via feedback forms). The PrEQoL study will inform a subsequent study tilted SEQoL ‘Scaled collection of socioEconomic and Quality of Life data from patients undergoing allogeneic haematopoietic cell transplantation in the UK’. We anticipate the findings from PrEQoL and SEQoL will provide insight on inequity at both the individual patient and the system level and influence planning and provision of future HCT services.
Health professionals’ perspectives on Patient Reported Outcome Measures (PROMS) in the hematopoietic cell transplant pathway
Background: Patient Reported Outcome Measures (PROMs) are being increasingly used to assess the impact of disease and treatment on patient quality of life (QoL) and symptoms. At present patient reported outcome (PRO) data is not routinely collected in hematopoietic cell transplant (HCT) centres. Little is known about health professionals’ views or the factors influencing PRO data collection and PROMS use.
Aim: The purpose of this study is to identify enablers and barriers to PRO data collection and PROMs use at HCT centres in the UK. This study will include investigating the knowledge and attitudes of HCT professionals towards PRO data collection and existing PROM tools.
Method: An online survey will be distributed to health professionals within the UK who identify as working with HCT recipients. Survey items will be developed based on the Consolidated Framework for Implementation Research (CFIR) which classifies barriers and enablers to practice adoption into intervention, external organisational, internal organisational, individual and process related factors.
Results: Data from this survey will be used to identify enablers and barriers to PRO data collection across the HCT community in the UK. Specifically, this survey will provide insight on factors internal to specific HCT centres which may impact on PRO data collection including resource, capacity, knowledge and beliefs about PROMs.
Impact: The study findings will be used to the roll-out strategy of the ‘SEQoL’ programme which aims to collect socioeconomic and QoL data from HCT recipients.
Understanding patients views towards patient-reported outcome and socioeconomic data collection
The research team are working with Patient Advisory Group members to co-design a qualitative interview study to explore patient views about how socioeconomic and PRO data should be collected in the HCT setting. It is hoped that during the interview study patients will share their perspectives on i) how and when this type of data should be collected and II) whether existing PRO tools reflect the patient experience of wellbeing after a stem cell transplant.
Meet the researchers
Dr Gemma Pugh
Dr Gemma Pugh
Head of Patient-Reported Outcomes Research
Gemma is the Head of Patient-Reported Outcomes Research at Anthony Nolan and research lead within the Patient Services team. She has a PhD in Behavioural Science and a specific research interest in cancer survivorship. She has led various studies to investigate cancer incidence, survival outcomes and health behaviour change among children and young people.
Her research includes using quantitative and qualitative methods to understand patient, caregiver and professionals’ experiences and expectations of health care. Prior to joining Anthony Nolan, she worked in Aotearoa, New Zealand managing the New Zealand Children’s Cancer Registry (NZCCR) where she led analysis investigating differences in survival outcomes between ethnic groups.
Meet the researchers
Dr Christina Yiallouridou
Dr Christina Yiallouridou
Research Officer for Patient Services
Christina is the Research Officer for Patient Services at Anthony Nolan, bringing a wealth of knowledge and experience to her role. Christina has a PhD in Vision Sciences from Cardiff University and a background in neuroimaging and pharmacology. Her previous work includes exploring patient and healthcare practitioner perspectives of intravitreal treatment and investigating predictive factors of post-operative pain.
Christina has expertise in both qualitative and quantitative research methods. She is keen to apply her research experience to explore the quality of life of individuals who undergo stem cell transplantation, with a particular focus on exploring quality of life outcomes and symptom burden.